PRHSX : T. ROWE PRICE HEALTH SCIENCES

 
 
 
4
 

ZACKS RANK: 4 - SELL

Ticker: PRHSX
Manager: Taymour R. Tamaddon
Manager Since: 12/13
NAV (07/28/2014): 65.84
Objective: Health Care - Equity
Peer: HL MG
Net Assets ($mil): 8578.00
Inception: 12/29/1995
PRHSX : Description

The fund was incepted in December 1995 and is managed by T.Rowe Price Associates. This health fund's main objective is long-term capital appreciation. The fund invests at least 80% of its net assets in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. The fund may invest in companies of any size, the majority of fund assets are invested in large and mid capitalization companies. Dividends and capital gains, if any, are declared annually in December.

PRHSX : Composition - 07/14
Stocks 98.15%
Foreign Stocks 10.96%
Cash 1.58%
Bonds 0.00%
Foreign Bonds 0.00%
Preferred 0.04%
Convertible 0.22%
Other 0.01%
Foreign Hedged 0.00%
Composition Horizontal Bar Chart
PRHSX : Style Analysis - 07/14
Large Growth 56.96%
Large Value 0.00%
Small Growth 0.00%
Small Value 0.00%
Foreign Stock 56.96%
Emerging Market 0.00%
Precious Metals 0.00%
Intermediate Bond 20.02%
High Yield Bond 0.00%
Foreign Bond 0.00%
Style Analysis Horizontal Bar Chart
PRHSX : Risk Analysis
Beta v. S&P 500 0.85
Beta v. EAFE 0.10
Beta v. Barclays Agg Bond 0.44
Alpha 3 Yr 10.92
Alpha 5 Yr 9.83
R-Sq 3 Yr 0.56
R-Sq 5 Yr 0.62
Std Dev 3 Yr 15.51
Std Dev 5 Yr 15.52
Sharpe 3 Yr 1.86
Sharpe 5 Yr 1.89
PRHSX : Fees
Expense Ratio 0.79
% Max Load NA
% Min Load NA
% Deferred Load NA
% Redemption NA
% Max 12 B1 Fee 0.00
% Max Mgt Fee 0.64
PRHSX : Purchase Choices:
Min Initial Investment 2500
Min Subsequent Investment 100
PRHSX : Returns Analysis - Annual

Line chart

  2004200520062007200820092010201120122013YTD
NAV ($) 23.1125.0726.1328.3219.8026.1730.2832.6041.2257.8065.84
Total Return (%) 15.8413.539.5718.74-28.7732.1716.3211.0031.9351.3910.64
Annual Dividend Yield (%) 0.000.000.000.000.000.000.000.000.310.000.00
Relative Performance
Rel Performance-S&P500(%) 49.6786.42-62.17132.5282.3757.5112.6289.07159.41190.1435.25
Rel Performance-Obj.Ret.(%) 70.6045.7058.4498.82-50.74102.9583.0132.58127.0250.88-9.37
Ret.Quintile vs Obj(1 is best) 12215111124
Turnover, Yields, and Gains
Fund Assets Net($mil) 1,3291,3421,7142,2951,7002,1572,4833,0735,0168,5788,578
Annual Turnover (%) 44.1055.7048.8044.8047.4033.4036.4023.3012.9045.700.00
Annual Dividend Paid ($) 0.000.000.000.000.000.000.000.000.140.000.00
Annual Capital Gains Paid($) 0.001.161.342.680.340.000.160.961.674.430.00
PRHSX : Returns Analysis - Trailing Total Return
  1 Month 3 Month 6 Month YTD 1 Year 3 Year 5 Year 10 Year 15 Year 20 Year
Total Return (through 07/14) 3.41% 4.39% 10.64% 10.64% 40.45% 27.48% 27.98% 15.26% 13.96% NA
Ret. Percentile vs. Obj. (1 is best) 73 62 63 63 18 21 7 7 9 NA
PRHSX : Stock Portfolio Snapshot - 07/14
Average Price/Earnings 26.91
Average Price/Book 4.72
Average EPS Growth 15.29
Average Market Value 37,343.00
PRHSX : Stock Sector Breakout - 07/14
Stock Sector Breakout
PRHSX : Top Holdings - 07/14
Name Weight Shares
GILEAD SCIENCES INC 6.10 8,033,400
ALEXION PHARMACEUTICALS INC 4.63 2,840,100
UNITEDHEALTH GROUP INC 4.30 4,890,868
BIOGEN IDEC INC 3.51 1,069,100
INCYTE PHARMACEUTICALS INC 2.52 4,389,800
AETNA INC 3.11 3,869,283
VALEANT PHARMACEUTICALS 2.95 2,087,600
AGILENT TECHNOLOGIES INC 2.64 4,405,330
MCKESSON CORP 3.24 1,712,900